QIAGEN NV (QGEN)
45.32
-0.34
(-0.74%)
USD |
NYSE |
Dec 11, 12:22
QIAGEN Total Liabilities (Quarterly): 2.904B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InflaRx NV | 23.25M |
| CDT Equity, Inc. | 4.274M |
| LENZ Therapeutics, Inc. | 16.78M |
| Liminatus Pharma, Inc. | 2.988M |
| Oruka Therapeutics, Inc. | 22.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.553B |
| Shareholders Equity (Quarterly) | 3.649B |
| Debt to Equity Ratio | 0.5829 |
| Current Ratio | 2.600 |
| Net Debt Paydown Yield | -1.50% |